Table 1 Comparison of baseline characteristics in the TBI group and the TBI + Lyc group. CRP C-reactive protein, PCT procalcitonin, GCS Glasgow coma Scale, SOFA sequential organ failure assessment, APACHE II, acute physiology and chronic health evaluation II.
TBI group (n = 35) | TBI + Lyc group (n = 32) | P value | |
|---|---|---|---|
Male sex, n (%) | 26.00 (74.29%) | 26.00 (81.25%) | 0.495 |
Age (years), (mean ± SD) | 59.71 ± 13.64 | 58.31 ± 14.75 | 0.687 |
Comorbidity | |||
Hypertension, n (%) | 12.00 (34.29%) | 11.00 (34.38%) | 0.994 |
Type 2 diabetes, n (%) | 9.00 (25.71%) | 6.00 (18.75%) | 0.495 |
Coronary atherosclerotic cardiopathy, n (%) | 3.00 (8.57%) | 1.00 (3.13%) | 0.672 |
Sequelae of cerebral infarction, n (%) | 2.00 (5.71%) | 1.00 (3.13%) | 1.000 |
Surgery, n (%) | 16.00 (45.71%) | 18.00 (56.25%) | 0.389 |
Start time (minutes), median (IQR) | 94.00 (78.50, 148.25) | 93.00 (79.50, 268.25) | 0.769 |
Duration (minutes), (mean ± SD) | 208.50 ± 92.42 | 220.00 ± 51.94 | 0.653 |
CRP (mg/L), median (IQR) | 11.21 (2.09, 35.63) | 14.01 (2.78, 31.15) | 0.816 |
PCT (ng/mL), median (IQR) | 0.51 (0.14, 1.43) | 0.48 (0.13, 1.46) | 0.688 |
Intestinal function assessment | |||
Gastrointestinal function score | |||
Grade 0, n (%) | 12.00 (34.29%) | 13.00 (40.63%) | 0.592 |
Grade I, n (%) | 14.00 (40.00%) | 12.00 (37.50%) | 0.834 |
Grade II, n (%) | 9.00 (25.71%) | 7.00 (21.88%) | 0.713 |
Ultrasound (scores), median (IQR) | 1.00 (0.00, 3.00) | 1.00 (0.00, 2.00) | 0.434 |
Neurological deficit assessment | |||
Helsinki CT (scores), (mean ± SD) | 6.23 ± 2.81 | 5.81 ± 3.29 | 0.578 |
GCS (scores), median (IQR) | 5.00 (3.00, 9.00) | 6.00 (4.25, 9.00) | 0.525 |
SOFA (scores), (mean ± SD) | 6.86 ± 2.84 | 6.09 ± 2.93 | 0.283 |
APACHE II (scores), (mean ± SD) | 21.97 ± 7.05 | 21.19 ± 6.91 | 0.648 |
Mortality risk (%), (mean ± SD) | 40.68 ± 25.79 | 39.98 ± 23.98 | 0.909 |
